1000003271

Cadila Healthcare

460.85
+2.65 (0.58%) NSE

Last updated on 29 Dec 2021 10:11 AM

Returns
-1.34%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

46897.65

Earning Per Share

14.42

Dividend Yield

0.79%

P/E Ratio

30.57

P/B Ratio

3.65

Debt to Equity

0.32

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value

5.34% down side

up side5.34%


About the company

Cadila Healthcare Ltd is a well known research-oriented, technology-driven pharmaceutical company focused on the research areas of biotechnology, formulations and Active Pharmaceutical Ingredients. They are an Indian based pharmaceutical company having their presence around the world. They are having their manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Cadila Healthcare Ltd, the flagship of Zydus Cadila Group was incorporated in May 1995 and they became a public limited company in July 1996. The company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.

Similar Companies